Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y

Fresenius Medical Care AG & Co. (FMS) reported fourth-quarter 2024 adjusted earnings per share (EPS) of 48 cents, which surpassed the Zacks Consensus Estimate by 17.1%. The bottom line improved 2.1% year over year.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.FMS’ Revenue DetailsRevenues of $5.43 billion (EUR 5,085 million) surpassed the Zacks Consensus Estimate by 0.7%. The company’s reported revenues were up 1.9% year over year and 1.6% at constant currency (cc). Also, revenues ...